Page last updated: 2024-08-25
ropivacaine and Systemic Inflammatory Response Syndrome
ropivacaine has been researched along with Systemic Inflammatory Response Syndrome in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, X; Dong, S; Liao, L; Liu, J; Liu, Y; Zeng, L; Zhang, T | 1 |
Trials
1 trial(s) available for ropivacaine and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Study on the protective mechanism of dexmedetomidine on the liver of perioperative diabetic patients: A randomized controlled trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Biomarkers; Blood Glucose; Cholesterol; Dexmedetomidine; Diabetes Mellitus, Type 2; Humans; Interleukin-6; Liver; Ropivacaine; Saline Solution; Superoxide Dismutase; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2022 |